Droxit Trademark (Class 5) — Ready for Examination Status & Details
Source: Indian Trademark Registry (ipindia.gov.in) · IP India record as of 02/09/2026 · Indexed 2026-09-02 · Last updated 2 Sep 2026
Trademark Fact Sheet
- Trademark (as filed)
- DroxitWORD
- Application No.
- 7969359
- Filed
- 02/09/2026
- Status
- Ready for Examination
- Class(es)
- Class 5
- TM Office
- CHENNAI
- Owner's state
- Tamil Nadu
- TM type
- WORD
Goods & Services
Dydrogesterone Droxit is a dydrogesterone-based hormonal formulation intended to support progesterone-related therapy. It is used in the management of menstrual irregularities and other conditions associated with progesterone deficiency.
Owner
- Name
- ELBRIT LIFE SCIENCES PVT LTD Body Incorporate4 trademarks filed under this owner
- Address
- *****, Erode District - 638011(dot)
- *********ort(at)elbrit.org
- State
- Tamil Nadu
- MCA company
- Elbrit Life Sciences Private LimitedActiveCIN U74999TZ2014PTC029965 · Incorporated 2014
Other trademarks by this owner
3 other marks filed under ELBRIT LIFE SCIENCES PVT LTD Body Incorporate. Live marks link to their full details.
Application Timeline
Filing claims & diligence
- First use claim
- 06/03/2023
- Filing mode
- e-Filing
- Category
- TRADE MARK
What does this status mean?
Droxit is a trademark application in Class 5. Track its live status and get notified the moment it changes.
Frequently asked questions
The trademark Droxit (Application No. 7969359) is owned by (1) ELBRIT LIFE SCIENCES, as recorded in the Indian Trademark Registry. Trademark ownership in India is determined by the Trade Marks Act, 1999 and the Trade Marks Rules, 2017.
The current status of Droxit is "Ready for Examination". It was filed on 02/09/2026 at CHENNAI in Class 5. Status may change over time as the application moves through examination, publication, opposition and registration stages.
Droxit is filed in Class 5, covering: Dydrogesterone Droxit is a dydrogesterone-based hormonal formulation intended to support progesterone-related therapy. It is used in the management of menstrual irregularities and other conditions associated with progesterone deficiency.
Droxit covers: Dydrogesterone Droxit is a dydrogesterone-based hormonal formulation intended to support progesterone-related therapy. It is used in the management of menstrual irregularities and other conditions associated with progesterone deficiency.
The exact word "Droxit" is already on record at the Indian Trademark Registry under Application No. 7969359. If you intend to use a similar mark for similar goods or services, you should conduct a comprehensive availability search and consult a trademark attorney before filing. Registerkaro offers a free availability check followed by professional filing.
Indian registered trademarks are valid for 10 years from the date of registration and can be renewed indefinitely in 10-year blocks. Droxit (App #7969359) is currently in status "Ready for Examination" — renewal dates apply only after registration is granted.
If Droxit is in the "Advertised before Acceptance" or "Accepted & Advertised" stage, you have a 4-month window from publication in the Trade Marks Journal to file an opposition (Form TM-O) at the same Trade Marks Registry office. Grounds typically include prior rights, descriptiveness or bad faith. Registerkaro can prepare and file a Notice of Opposition for you.
— Public Notice —
Protect a mark like "Droxit"
Free availability check, attorney drafting, and end-to-end TM-A filing through Registerkaro. Pick the plan that fits — government fee additional.
For individuals or companies who just want to file a trademark.
- Help choosing the right trademark class
- Drafting & Filing by TM Expert + Power of Attorney form
- Acknowledgement Receipt
- TM usage guide